The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro
References
- Kotnik T, Kramar P, Pucihar G, Miklavcic D, Tarek M. Cell membrane electroporation-part 1: the phenomenon. IEEE Electr Insul Mag 2012; 28: 14-23. 10.1109/MEI.2012.6268438
- Weaver JC. Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 1993; 51: 426-35. 10.1002/jcb.2400510407
- Tsong TY. Electroporation of cell membranes. Biophys J 1991; 60: 297-306. 10.1016/S0006-3495(91)82054-9
- Kotnik T, Rems L, Tarek M, Miklavčič D. Membrane electroporation and electropermeabilization: mechanisms and models. Annu Rev Biophys 2019; 48. 10.1146/annurev-biophys-052118-115451
- Yarmush ML, Golberg A, Serša G, Kotnik T, Miklavčič D. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 2014; 16: 295-320. 10.1146/annurev-bio-eng-071813-104622
- Jiang C, Davalos RV, Bischof JC. A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng 2015; 62: 4-20. 10.1109/TBME.2014.2367543
- Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AA, Vieveen JM, Bouwman AR, et al. Irreversible electroporation for nonthermal tumor Ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol 2014; 25: 997-1011. 10.1016/j.jvir.2014.01.028
- Mali B, Jarm T, Snoj M, Serša G, Miklavčič D. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol 2013; 39: 4-16. 10.1016/j.ejso.2012.08.016
- Haberl S, Miklavčič D, Serša G, Frey W, Rubinsky B. Cell membrane electroporation – part 2: the applications. Electr Insul Mag IEEE 2013; 29: 29-37. 10.1109/MEI.2013.6410537
- Cadossi R, Ronchetti M, Cadossi M. Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy. Future Oncol 2014; 10: 877-90. 10.2217/fon.13.235
- Kotnik T, Frey W, Sack M, Meglič SH, Peterka M, Miklavčič D. Electroporationbased applications in biotechnology. Trends Biotechnol 2015; 33: 480-8. 10.1016/j.tibtech.2015.06.002
- Golberg A, Sack M, Teissie J, Pataro G, Pliquett U, Saulis G, et al. Energy-efficient biomass processing with pulsed electric fields for bioeconomy and sustainable development. Biotechnol Biofuels 2016; 9: 94. 10.1186/s13068-016-0508-z
- Toepfl S, Siemer C, Saldaña-Navarro G, Heinz V. Overview of pulsed electric fields processing for food. In: Sun DW, editor. Emerging technologies for food processing Second edition. Amsterdam: Academic press; Elsevier; 2014. p. 93-114. 10.1016/B978-0-12-411479-1.00006-1
- Mahnič-Kalamiza S, Vorobiev E, Miklavčič D. Electroporation in food processing and biorefinery. J Membr Biol 2014; 247: 1279-304. 10.1007/s00232-014-9737-x
- Campana LG, Edhemović I, Soden D, Perrone AM, Scarpa M, Campanacci L, et al. Electrochemotherapy - emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol 2019; 45: 92-102. 10.1016/j.ejso.2018.11.023
- Miklavčič D, Mali B, Kos B, Heller R, Serša G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng OnLine 2014; 13: 29. 10.1186/1475-925X-13-29
- Mir LM, Gehl J, Serša G, Collins CG, Garbay J-R, Billard V, et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 2006; 4: 14-25. 10.1016/j.ejcsup.2006.08.003
- Gehl J, Serša G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol Stockh Swed 2018; 57: 874-82. 10.1080/0284186X.2018.1454602
- Marty M, Serša G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3-13. 10.1016/j.ejcsup.2006.08.002
- Mir LM, Tounekti O, Orlowski S. Bleomycin: revival of an old drug. Gen Pharmacol 1996; 27: 745-8. 10.1016/0306-3623(95)02101-9
- Tounekti O, Pron G, Belehradek J, Mir LM. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 1993; 53: 5462-9. PMID: 7693342
- Spreckelmeyer S, Orvig C, Casini A. Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin. Molecules 2014; 19: 15584-610. 10.3390/molecules191015584
- Serša G, Čemažar M, Miklavčič D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 1995; 55: 3450-5. PMID: 7614485
- Tozon N, Serša G, Čemažar M. Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats. Anticancer Res 2001; 21: 2483-8. PMID: 11724311
- Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 2000; 11: 201-8. PMID: 10831279
- Županič A, Ribarič S, Miklavčič D. Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy. Neoplasma 2007; 54: 246-50. PMID: 17447858
- Miklavčič D, Pucihar G, Pavlovec M, Ribarič S, Mali M, Maček-Lebar A, et al. The effect of high frequency electric pulses on muscle contractions and antitumor efficiency in vivo for a potential use in clinical electrochemotherapy. Bioelectrochemistry 2005; 65: 121-8. 10.1016/j.bioelechem.2004.07.004
- Arena CB, Davalos RV. Advances in therapeutic electroporation to mitigate muscle contractions. J Membr Sci Technol 2012; 2: 1-3. 10.4172/2155-9589.1000e102
- Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “Out of Operating Theater” anesthesia. Anesth Analg 2010; 110: 1305-9. 10.1213/ANE.0b013e3181d27b30
- Mali B, Jarm T, Čorović S, Paulin-Kosir MS, Čemažar M, Serša G, et al. The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 2008; 46: 745-57. 10.1007/s11517-008-0346-7
- Deodhar A, Dickfeld T, Single GW, Hamilton WC, Thornton RH, Sofocleous CT, et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR Am J Roentgenol 2011; 196: W330-5. 10.2214/AJR.10.4490
- Golberg A, Rubinsky B. Towards electroporation based treatment planning considering electric field induced muscle contractions. Technol Cancer Res Treat 2012; 11: 189-201. 10.7785/tcrt.2012.500249
- Yao C, Dong S, Zhao Y, Lv Y, Liu H, Gong L, et al. Bipolar microsecond pulses and insulated needle electrodes for reducing muscle contractions during irreversible electroporation. IEEE Trans Biomed Eng 2017; 64: 2924-37. 10.1109/TBME.2017.2690624
- Sano MB, Fan RE, Cheng K, Saenz Y, Sonn GA, Hwang GL, et al. Reduction of muscle contractions during irreversible electroporation therapy using high-frequency bursts of alternating polarity pulses: a laboratory investigation in an ex vivo swine model. J Vasc Interv Radiol JVIR 2018; 29: 893-8.e4. 10.1016/j.jvir.2017.12.019
- Latouche EL, Arena CB, Ivey JW, Garcia PA, Pancotto TE, Pavlisko N, et al. High-frequency irreversible electroporation for intracranial meningioma: A feasibility study in a spontaneous canine tumor model. Technol Cancer Res Treat 2018; 17: 1-10. 10.1177/1533033818785285
- Dong S, Wang H, Zhao Y, Sun Y, Yao C. First human trial of high-frequency irreversible electroporation therapy for prostate cancer. Technol Cancer Res Treat 2018; 17: 1-9. 10.1177/1533033818789692
- Arena CB, Sano MB, Rossmeisl JH, Caldwell JL, Garcia PA, Rylander M, et al. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction. Biomed Eng OnLine 2011; 10: 102. 10.1186/1475-925X-10-102
- Sweeney DC, Reberšek M, Dermol J, Rems L, Miklavčič D, Davalos RV. Quantification of cell membrane permeability induced by monopolar and high-frequency bipolar bursts of electrical pulses. Biochim Biophys Acta BBA - Biomembr 2016; 1858: 2689-98. 10.1016/j.bbamem.2016.06.024
- Pucihar G, Kotnik T, Teissié J, Miklavčič D. Electropermeabilization of dense cell suspensions. Eur Biophys J 2007; 36: 173-85. 10.1007/s00249-006-0115-1
- Dermol J, Miklavčič D. Mathematical models describing chinese hamster ovary cell death due to electroporation in vitro. J Membr Biol 2015; 248: 865-81. 10.1007/s00232-015-9825-6
- Dermol-Černe J, Miklavčič D, Reberšek M, Mekuč P, Bardet SM, Burke R, et al. Plasma membrane depolarization and permeabilization due to electric pulses in cell lines of different excitability. Bioelectrochemistry 2018; 122:103-14. 10.1016/j.bioelechem.2018.03.011
- Jakštys B, Ruzgys P, Tamošiūnas M, Šatkauskas S. Different cell viability assays reveal inconsistent results after bleomycin electrotransfer in vitro. J Membr Biol 2015; 248: 857-63. 10.1007/s00232-015-9813-x
- Serša G, Štabuc B, Čemažar M, Miklavčič D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 2000; 6: 863-7. PMID: 10741708
- Čemažar M, Jarm T, Miklavčič D, Maček Lebar A, Ihan A, Kopitar NA, et al. Effect of electric-field intensity on electropermeabilization and electrosensitivity of various tumor-cell lines in vitro. Electro-Magnetobiology 1998; 17: 263-72. doi.org/10.3109/15368379809022571
- Dermol-Černe J, Vidmar J, Ščančar J, Uršič K, Serša G, Miklavčič D. Connecting the in vitro and in vivo experiments in electrochemotherapy - a feasibility study modeling cisplatin transport in mouse melanoma using the dual-porosity model. J Control Release 2018; 286: 33-45. 10.1016/j.jconrel.2018.07.021
- Sano MB, Arena CB, Bittleman KR, DeWitt MR, Cho HJ, Szot CS, et al. Bursts of Bipolar Microsecond Pulses Inhibit Tumor Growth. Sci Rep 2015; 5: 14999. 10.1038/srep14999
- Puc M, Kotnik T, Mir LM, Miklavčič D. Quantitative model of small molecules uptake after in vitro cell electropermeabilization. Bioelectrochemistry Amst Neth 2003; 60: 1-10. 10.1016/S1567-5394(03)00021-5
- Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 1998; 9: 319-25. PMID: 9635922
- Pucihar G, Kotnik T, Miklavčič D, Teissié J. Kinetics of transmembrane transport of small molecules into electropermeabilized cells. Biophys J 2008; 95: 2837-48. 10.1529/biophysj.108.135541
- Čemažar M, Serša G, Miklavčič D. Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin. Anticancer Res 1998; 18: 463-6. PMID: 9891510
- Saczko J, Kamińska I, Kotulska M, Bar J, Choromańska A, Rembiałkowska N, et al. Combination of therapy with 5-fluorouracil and cisplatin with electroporation in human ovarian carcinoma model in vitro. Biomed Pharmacother 2014; 68: 573-80. 10.1016/j.biopha.2014.05.005
- Žakelj M, Prevc A, Kranjc S, Čemažar M, Todorovič V, Savarin M, et al. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts. Oncol Rep 2019; 41: 1658-68. 10.3892/or.2019.6960
- Todorovič V, Serša G, Flisar K, Čemažar M. Enhanced cytotoxicity of bleomycin and cisplatin after electroporation in murine colorectal carcinoma cells. Radiol Oncol 2009; 43: 264-73. 10.2478/v10019-009-0037-5
- Vásquez JL, Ibsen P, Lindberg H, Gehl J. In vitro and in vivo experiments on electrochemotherapy for bladder cancer. J Urol 2015; 193: 1009-15. 10.1016/j.juro.2014.09.039
- Kranjc M, Markelc B, Bajd F, Čemažar M, Serša I, Blagus T, et al. In situ monitoring of electric field distribution in mouse tumor during electroporation. Radiology 2015; 274: 115-23. 10.1148/radiol.14140311
- Čorović S, Pavlin M, Miklavčič D. Analytical and numerical quantification and comparison of the local electric field in the tissue for different electrode configurations. Biomed Eng OnLine 2007; 6: 37. 10.1186/1475-925X-6-37
- Dong S, Yao C, Zhao Y, Lv Y, Liu H. Parameters optimization of bipolar high frequency pulses on tissue ablation and inhibiting muscle contraction. IEEE Trans Dielectr Electr Insul 2018; 25: 207-16. 10.1109/TDEI.2018.006303
- Zhao Y, Bhonsle S, Dong S, Lv Y, Liu H, Safaai-Jazi A, et al. Characterization of conductivity changes during high-frequency irreversible electroporation for treatment planning. IEEE Trans Biomed Eng 2018; 65: 1810-9. 10.1109/TBME.2017.2778101
- Siddiqui IA, Latouche EL, DeWitt MR, Swet JH, Kirks RC, Baker EH, et al. Induction of rapid, reproducible hepatic ablations using next-generation, high frequency irreversible electroporation (H-FIRE) in vivo. HPB 2016; 18: 726-34. 10.1016/j.hpb.2016.06.015
- Siddiqui IA, Kirks RC, Latouche EL, DeWitt MR, Swet JH, Baker EH, et al. High-frequency irreversible electroporation: Safety and efficacy of next-generation irreversible electroporation adjacent to critical hepatic structures. Surg Innov 2017; 24: 276-83. 10.1177/1553350617692202
- Arena CB, Garcia PA, Sano MB, Olson JD, Rogers-Cotrone T, Rossmeisl JH, et al. Focal blood-brain-barrier disruption with high-frequency pulsed electric fields. Technology 2014; 2: 206-13. 10.1142/S2339547814500186
- Rogers WR, Merritt JH, Comeaux JA, Kuhnel CT, Moreland DF, Teltschik DG, et al. Strength-duration curve for an electrically excitable tissue extended down to near 1 nanosecond. IEEE Trans Plasma Sci 2004; 32: 1587-99. 10.1109/TPS.2004.831758
- Mercadal B, Arena CB, Davalos RV, Ivorra A. Avoiding nerve stimulation in irreversible electroporation: a numerical modeling study. Phys Med Biol 2017; 62: 8060-79. 10.1088/1361-6560/aa8c53
- van den Honert C, Mortimer JT. The response of the myelinated nerve fiber to short duration biphasic stimulating currents. Ann Biomed Eng 1979; 7: 117-25. 10.1007/BF02363130
- Sano MB, Fan RE, Xing L. Asymmetric waveforms decrease lethal thresholds in high frequency irreversible electroporation therapies. Sci Rep 2017; 7: 40747. 10.1038/srep40747
- Valdez CM, Barnes R, Roth CC, Moen E, Ibey B. The interphase interval within a bipolar nanosecond electric pulse modulates bipolar cancellation. Bioelectromagnetics 2018; 39: 441-50. 10.1002/bem.22134
- Bhonsle SP, Arena CB, Sweeney DC, Davalos RV. Mitigation of impedance changes due to electroporation therapy using bursts of high-frequency bipolar pulses. Biomed Eng Online 2015; 14(Suppl 3): S3. 10.1186/1475-925X-14-S3-S3
- Kotnik T, Miklavčič D, Mir LM. Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part II. Reduced electrolytic contamination. Bioelectrochemistry 2001; 54: 91-5. 10.1016/S1567-5394(01)00115-3
Language: English
Page range: 194 - 205
Submitted on: Feb 4, 2019
Accepted on: Apr 23, 2019
Published on: Jun 1, 2019
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2019 Maria Scuderi, Matej Rebersek, Damijan Miklavcic, Janja Dermol-Cerne, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.